Paloma Partners Management CO Dexcom Inc Call Options Transaction History

Paloma Partners Management CO

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $258,681 - $301,254	2,300 New	2,300 $295,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $419,924 - $517,990	-5,500 Reduced 61.11%	3,500 $282,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $611,910 - $1.2 Million	9,000 New	9,000 $670,000
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $672,273 - $902,034	-6,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $1.42 Million - $1.89 Million	-17,500 Reduced 73.53%	6,300 $2.69 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $1.01 Million - $1.36 Million	13,000 Added 120.37%	23,800 $8.8 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $1.03 Million - $1.22 Million	10,800 New	10,800 $4.45 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $86,304 - $120,652	-3,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $87,017 - $118,358	3,100 New	3,100 $369,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.